Company intelligence / Profile preview

Liaoning Meizilin Pharmaceutical

Liaoning Sheng, Chinadnb.com ↗

Ownership: Private
Development stage: Commercial

Overview

Liaoning Meilin Pharmaceutical Co. Ltd. is a private pharmaceutical company based in Liaoning Province, China, founded in 2002. The company's main known asset is trapidil, a small molecule cGMP-PDE inhibitor originally developed by Mochida and approved for coronary artery disease in Japan since 1981; it also has been investigated for other indications such as dyskinesia but with inactive status there. The company's pipeline appears limited to this single asset based on available data.

Therapeutic areas: CardiovascularNeurology
Modalities: Small molecule drug
Industry: Biotech

Drug pipeline

1 asset

fluorescein sodium

Commercial

Indications: Ophthalmic diagnostics

Partnerships

Mochida Pharmaceutical Co., Ltd. – originator of trapidil and likely licensing partner.

Beyond the preview

Go deeper on Liaoning Meizilin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Meizilin Pharmaceutical.

Explore the full profile